Oral ritodrine and preterm premature rupture of membranes
- PMID: 3903579
Oral ritodrine and preterm premature rupture of membranes
Abstract
A prospective randomized study was performed to determine whether or not oral ritodrine therapy significantly prolonged the latent period in patients with prematurely ruptured membranes. Compared with a control group of similar patients, those treated had a significantly prolonged mean latent period. In addition, 47.6% of the treatment group versus 14.2% of the control group had a latent period of more than one week.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources